Skip to main content

Table 2 Ingenuity canonical pathways associated with the proteins identified as differentially expressed between MCF7Ecadvar and MCF7pcDNA3 cells. Results obtained with the IPA tool

From: Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B

Ingenuity canonical pathways

-log(p value)

Proteins involved

Glycolysis

0.0836

G6PI, TPIS, PGAM1, F16P1, ALDOA

Gluconeogenesis

0.0827

G6PI, PGAM1, F16P1, ALDOA, MAOX

Protein ubiquitination pathway

0.0535

PSB3, PSA6, HS90B, GRP75, HS71A, HS71B, HS90A, UBA1

14–3-3-mediated signaling

0.0486

1433 T, GRB2, PDIA3, 1433Z, VIME

p70S6K signaling

0.0483

1433 T, GRB2, PDIA3, EF2, 1433Z

PI3K/AKT signaling

0.0478

1433 T, HS90B, GRB2, 1433Z, HS90A

Pentose phosphate pathway (oxidative branch)

0.0439

6PGL, G6PD

Aldosterone signaling in epithelial cells

0.0431

HS90B, PDIA3, GRP75, HS71A, HS71B, HS90A

PPARα/RXRα activation

0.0413

HS90B, GRB2, GPDM, PDIA3, HS90A

Glucocorticoid receptor signaling

0.0410

HS90B, GRB2, ACTB, GRP75, HS71A, HS71B, HS90A

  1. List of the ten canonical pathways most altered in MCF7Ecadvar cells compared with MCF7pcDNA3. They were ordered in a descending form according to the number of the negative of the logarithm of the p value assigned to each of them. The symbol of the proteins identified with differential expression levels between both cell lines that were involved in each pathway are also indicated in the table. PPARα peroxisome proliferator-activated receiver α, RXRα retinoid X receiver α